AACR launches new On Demand sessions, providing 24/7 access to the virtual Annual Meeting

Dave Tuveson, MD, PhD
David A. Tuveson, MD, PhD, FAACR

Even before the official start of the American Association for Cancer Research Annual Meeting 2021, registered attendees will have on-demand access to dozens of sessions.

This year’s virtual Annual Meeting features more than 70 scientific sessions available for viewing starting Friday, April 9. Standard registration will include access to On Demand sessions and also to recordings of all live sessions and panels starting the day of the scheduled presentation and lasting through June 21, 2021.

The sessions available on demand will represent a cross section of important topics and will also include all of this year’s scientific achievement award lectures. For a complete listing of available on-demand sessions, please visit the online planner located on the virtual Annual Meeting website. On Demand sessions will be clearly labeled.

AACR President-Elect David A. Tuveson, MD, PhD, FAACR, said that the virtual Annual Meeting’s On Demand sessions will allow the AACR’s diverse global audience to survey topics and speakers that they want to pay close attention to during the meeting. In some ways, he said, the On Demand sessions can be used like movie trailers and previews that can help build excitement and spread the word about scientific sessions.

“You know that some cancer scientists are going to survey everything, look for interesting topics, look at the exact presentation, and if they get excited about that, they will tell their friends that they have to go to that session,” said Tuveson, director and Roy J. Zuckerberg professor of cancer research, Cold Spring Harbor Laboratory Cancer Center.

Most On Demand sessions will offer a related live 30-minute panel event featuring session presenters. The panelists will respond to previously submitted and live questions from the audience. To make it easier for attendees, the corresponding panel session will share the same name as the On Demand session, and links to the corresponding sessions are also conveniently located within the session descriptions.

Tuveson noted that at an in-person lecture where there’s more than 100 people, there’s often little time at the end for more than a couple of questions. But the On Demand sessions with related live panel presentations will greatly increase the number of questions that presenters can answer.

“A lot more questions are actually covered in these live virtual sessions than in live, in-person sessions, where it was just happenstance that your question got addressed. In those, you’d be lucky if you could speak to the lecturer afterwards,” Tuveson said.

Attendees who view an On Demand session prior to the live panel can submit questions in advance. Tuveson encourages those asking questions to include their name with the question so that even if the question isn’t asked during the session, presenters can follow up directly with the questioner through the meeting’s networking platform and increase engagement. Tuveson also encourages presenters to follow up as often as possible to help stimulate engagement during the virtual Annual Meeting.

Click here to view the On Demand sessions and the complete meeting program.

On Demand sessions available starting April 9 include:

Awards and Lectures

  • AACR Award for Lifetime Achievement in Cancer Research
  • AACR Award for Outstanding Achievement in Basic Cancer Research
  • AACR Award for Outstanding Achievement in Chemistry in Cancer Research
  • AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
  • AACR Distinguished Public Service Awards
  • AACR Gertrude B. Elion Cancer Research Award
  • AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
  • AACR Team Science Award
  • AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention
  • AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
  • AACR-G.H.A. Clowes Award for Outstanding Basic Research
  • AACR-Irving Weinstein Foundation Distinguished Lectureship
  • AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research
  • AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
  • AACR-Princess Takamatsu Memorial Lectureship
  • AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research
  • AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research
  • AACR-Women in Cancer Research Charlotte Friend Lectureship
  • Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research

Major Symposia

  • AACR-Bayard D. Clarkson Symposium on Stem Cells, Leukemia, and the Niche
  • AACR-CSCO Joint Symposium: Single-Cell Analysis — Changing the Landscape of Cancer Research
  • AACR-JCA Joint Session: Tracking Tumor Evolutionary Dynamics: From Initiation through Metastasis
  • Advances in Cancer Nanotechnology
  • Alternative DNA Repair Pathways and Their Drug Targets
  • Artificial Intelligence in Cancer Imaging
  • Artificial Intelligence/Machine Learning in Cancer Research and Care: Progress and Opportunities
  • Cancer Immunometabolism
  • Cell-Surface Receptors in Immuno-Oncology: Discovery, Analysis, and Modulation
  • Colorectal Cancer Interception: Immunologic and Pharmacologic Advances
  • Deubiquitylating Enzymes (DUBs) as Targets for Cancer Therapy
  • Developing Rational Combinations of Targeted Drugs
  • Dharma Master Jiantai Symposium in Biomarkers: Mechanisms and Biomarkers of Response and Resistance to Immune Therapy
  • Dharma Master Jiantai Symposium in Targeted Therapy: New Combinations of Targeted Therapies and Immunotherapies
  • Diet, Clock, and Cancer
  • Drugging KRAS
  • Engineering and Modulating Natural Killer (NK) Cells for Cancer Immunotherapy
  • Familial Predisposition: Precision Medicine and Targeted Therapy
  • From ‘Omics Data to Prognostic and Predictive Biomarkers
  • Functional Precision Medicine in Cancer
  • Germline Influence on Immunotherapy Outcomes
  • Implications of Clonal Hematopoiesis in Human Health
  • Improving Therapy through Normalization of the Tumor Microenvironment
  • Innovative Molecular Approaches and Models to Advance Precision Health Equity
  • Matrix, Exosomes, and TME Cells in the Metastatic Niche
  • Metabolism and Chromatin Deregulation in Cancer and Cancer Heterogeneity
  • Modeling Metastatic Progression in the Mouse
  • Molecular Imaging
  • Neoadjuvant Immunotherapy for Melanoma and Other Cancers
  • New Approaches to Chimeric Antigen Receptor Engineering
  • Next Frontiers in Adjuvant Therapy
  • Next-Generation Epigenetic Drugs
  • Options and Opportunities for Treating Metastasis
  • Paracrine Signaling in Cancer
  • Phase Separation, Transcription, and Cancer
  • Progress from Personalized Cancer Vaccine Trials
  • T Cells in Cancer
  • The Cancer Dependency Map
  • The Clinical Proteomic Tumor Analysis Consortium: Building a Proteogenomic Atlas of Cancer
  • The Microbiome in Cancer Therapy: Hype or Hope?
  • The Tumor Microbiome and Its Role in Oncogenesis and Modulating Therapy Response
  • Towards Engineering of Neoantigen-Specific T-Cell Therapies
  • Tumor Cell Plasticity and Resistance to Cancer Therapies
  • Tumor Hypoxia and Genetic Instability: New Mechanisms and New Targets
  • When Is Transforming Growth Factor Beta Targetable?

Advances in Diagnostics and Therapeutics

  • Advances in Drug Delivery
  • Computational Methods for Immunogenomics and Precision Oncology
  • Diagnostic Tests for Immunotherapy: Current CLIA Lab Testing and Future Directions
  • Dharma Master Jiantai Advances in Lung Cancer Session: Understanding and Overcoming Resistance to Third-Generation EGFR and ALK Inhibitors
  • DNA Damage Response (DDR) Treatment: Evolving Diagnostic Approaches, Understanding of Replication Stress, and Resistance Mechanisms to DDR Targeting Therapies
  • Hybrid Technologies for Cancer Imaging, Theranostics, and Image-Guided Interventions
  • Management of Toxicity of Immune Cell Therapy
  • Noninvasive Monitoring of Minimal Residual Disease with Liquid Biopsies: Towards Real-Time Treatment Decision Making
  • Proton Therapy and FLASH Irradiation
  • Targeting Transcriptional Cyclin-Dependent Kinases in Cancer
  • Translational Canine Models Advancing Immunotherapy and Immunogenomics

Advances in Organ Site Research

  • Advances in Endometrial Cancer
  • Advances in Sarcoma Therapy
  • Developing More Effective Treatments for Triple-Negative Breast Cancer
  • Diffuse Large B-Cell Lymphoma
  • Emerging Concepts in Liver Cancer Research
  • Next-Generation Treatments for Melanoma: Building on Success
  • Pathways to Early Detection of Pancreatic Cancer
  • Solid Tumor Brain Metastasis
  • Targeting Signaling Pathways in Colorectal Cancer
  • Therapeutic Advances in Biliary Tract Cancers
  • Therapeutic Vulnerabilities and Resistance Mechanisms in Estrogen Receptor-Positive Breast Cancer

Advances in Prevention‚ Early Detection‚ and Interception

  • Connecting the Tumor Microenvironment with the Macroenvironment in Cancer Cachexia
  • Interception of Preneoplasia
  • Molecular Targets of Precision Prevention and Interception
  • Panel on Rural Cancer Control
  • Radiation-Induced Cancers and Cancer Survivorship

Advances in the Science of Cancer Health Disparities

  • Carcinogenic Exposures and Global Cancer Prevention
  • Pan-cancer Distinctions in Tumor Biology across Ethnicity and Genetic Ancestry
  • Precision Medicine in Underserved Populations

Special Sessions

  • Issues Important to Tobacco Control
  • AACR-ASCO Joint Session: Targets in the Treatment of Renal Cell Cancer
  • How Cancer Vaccines Help End the COVID-19 Pandemic
  • AACR-ONS Special Session: Symptom Science
  • Harnessing Novel Small-molecule and Immune-based Therapeutics for Maximum Patient Benefit: Stand Up To Cancer Open Scientific Session
  • Cancer Interception: Detecting and Stopping Cancer Earlier in Its Track: Stand Up To Cancer Open Scientific Session